Normal view MARC view ISBD view

Vismodegib in basal cell carcinoma.

Amaria, R N

Vismodegib in basal cell carcinoma. [electronic resource] - Drugs of today (Barcelona, Spain : 1998) Jul 2012 - 459-67 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

ISSN: 1699-3993

Standard No.: 10.1358/dot.2012.48.7.1808490 doi

Subjects--Topical Terms:
Anilides--adverse effects
Animals
Antineoplastic Agents--adverse effects
Carcinoma, Basal Cell--drug therapy
Drug Interactions
Drug Resistance, Neoplasm
Evidence-Based Medicine
Humans
Pyridines--adverse effects
Signal Transduction--drug effects
Skin Neoplasms--drug therapy
Treatment Outcome

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)